Generics BulletinTeva has broken new ground by publishing an ‘aide memoire’ document – a compilation of financial guidance and commentary for the firm’s current financial year “to assist investors with estimating its
Generics BulletinFines previously issued over a “pay for delay” agreement between Teva and Cephalon over Provigil (modafinil) should stand, according to an opinion delivered by an advocate general of the Court of Just
Pink SheetThe US Food and Drug Administration’s newly revised stand on testosterone labeling for cardiovascular risk is the visible tip of the metaphorical iceberg of years of effort that went into evaluating a
Pink SheetAfter another loss in the US Court of Appeals, Teva will seek a certiorari review by the US Supreme Court of its long-running inhaler patent case against Amneal . Teva had requested a full panel re